ArticleAmerican journal of lifestyle medicine2026
Test the Child, Uncover the High-Risk Parent: A Call to Expand Universal Pediatric Lipid Screening.
Article in American journal of lifestyle medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric lipid screening remains underutilized, despite recommendations from many professional societies. In particular, certain lipid disorders such as familial hypercholesterolemia and elevated lipoprotein (a) are highly heritable and detectable in childhood. This low uptake represents not only a missed opportunity to identify high-risk youth for atherosclerotic cardiovascular disease (ASCVD), but also a lost occasion to identify high-risk adult relatives through reverse cascade screening. Expanding universal pediatric lipid screening to include lipoprotein (a) can serve as an effective strategy to uncover undiagnosed ASCVD in their relatives. Early identification of affected, asymptomatic individuals could prevent ASCVD morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.